Cheryl Fitzer-Attas

Title: Innovations in Cancer Treatment by Cheryl Fitzer-Attas

Introduction

Cheryl Fitzer-Attas is a prominent inventor based in Rehovot, Israel. She has made significant contributions to the field of cancer research, particularly in the development of anti-tumor vaccines. With a total of 3 patents to her name, her work focuses on innovative approaches to combat various types of cancers.

Latest Patents

One of her latest patents involves tumor-associated antigen (TAA) peptides and their use as anti-tumor vaccines. This invention relates to TAA peptides derived from several sources, including Uroplakin Ia, Ib, II, and III, Prostate Specific Antigen (PSA), Prostate Acid Phosphatase (PAP), and Prostate Specific Membrane Antigen (PSMA). The patent emphasizes the potential of these peptides to prevent or cure bladder, prostate, breast, and other carcinomas. Most notably, the invention highlights TAA peptides that can be presented to the immune system by HLA-A2 molecules, enhancing their effectiveness as vaccines.

Career Highlights

Cheryl Fitzer-Attas is associated with Yeda Research and Development Co. Ltd., where she continues to advance her research in cancer immunotherapy. Her innovative work has positioned her as a key figure in the field, contributing to the development of therapies that could significantly improve patient outcomes.

Collaborations

Cheryl collaborates with esteemed colleagues, including Lea Eisenbach and Erez Bar-Haim. These partnerships enhance her research efforts and contribute to the advancement of cancer treatment methodologies.

Conclusion

Cheryl Fitzer-Attas is a trailblazer in the field of cancer research, with her innovative patents paving the way for new anti-tumor vaccines. Her contributions are vital in the ongoing fight against cancer, showcasing the importance of research and collaboration in developing effective treatments.